Following A -35.25% Weekly Decline, Is It Still A Buy For OptimizeRx Corp (NASDAQ: OPRX)?
OptimizeRx Corp (NASDAQ:OPRX)’s traded shares stood at 1.96 million during the last session, with the company’s beta value hitting 1.37. At the close of trading,